Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “A Decade of Innovation in Rare Diseases,” to document the significant progress made in the last 10 years in understanding a broad range of rare diseases and translating this knowledge into groundbreaking therapies for a variety of patient populations.
The report illustrates that more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350554-phrma-report-innovation-rare-diseases/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
AARP Travel's (http://travel.aarp.org), newest research on Romantic Travel reveals that 85% of Americans 45-plus have not taken a romantic vacation in the past two years. Therefore, AARP Love and Relationships Ambassador Dr. Pepper Schwartz explains in a new video that couples should plan a romantic getaway in order to spend quality time and bolster their relationship.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/66070-aarp-new-travel-website/
Anyone who has seen the blockbuster movies The Thomas Crown Affair or Bullitt will want to read The Pursuit of Happiness, a new novel by the same writer, Alan Trustman. The highest paid screenwriter in Hollywood at one time, Trustman now turns his pen to fiction, which reads and moves with the same crime thriller speed as his movies.
From the opening chapter we are rocketed into the world of a Boston bad boy who is recruited to work for the government.
“All of the material in The Pursuit of Happiness is true,” says Trustman. “Not a lot of people know that Boston was the contract killing capitol of the country throughout the 1940s – 1970s. Maybe later. I did a lot of research on the Boston gang wars.”
Media Contact: For a review copy of Silver Dollar or to arrange an interview with Alan Trustman, contact Scott Lorenz of Westwind Communications Book Marketing at scottlorenz@westwindcos.com or by phone at 734-667-2090 http://www.book-marketing-expert.com Thriller
At a time when educators and policymakers are placing a high priority on quality early childhood education, Wolf Trap Foundation for the Performing Arts today announced results of a four-year study showing that its arts integration teaching model bolsters young children’s math achievement. Additional resources, including a summary video with classroom demonstrations and the complete research report, may be accessed at http://www.wolftrap.org/stemartsstudy.
Conducted by independent evaluators at the American Institutes for Research (AIR), Findings from the Evaluation of the Wolf Trap Arts in Education Model (the Study) examined the effects of an arts-integrated teaching approach on teachers’ practice and students’ math knowledge.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7224251-wolf-trap-math-achievement/
At a time when cotton’s market share is threatened by synthetics, Cotton Incorporated responds with authenticity. The latest offerings in the 26-year run of the highly-regarded The Fabric Of Our Lives™ campaign from the not-for-profit research and promotion company focus on individual consumers and their personal stories of why cotton apparel items are their favorites.
Introducing the tagline, “Cotton. It’s Your Favorite for a Reason(SM),” the first commercial will launch on April 20 with thirty- and fifteen-second spots; additional commercials will be rolled out over the course of the year. The campaign also includes: a digital video series of consumer stories, some expanding on the stories told in the commercials; a unique, cotton-focused collaboration with online retailer Rue La La and a trade print advertisement.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7490551-new-cotton-incorporated-campaign/
At the end of June 2012 I learned through an Akashic Reading that my soul is from another star. My research led me to the 2012 Scenario website. I started tuning in to radio shows on InLight Radio including Let\'s Talk 2012 & Beyond which I find inspiring.
In mid August after hearing listeners talk about their personal galactic encounters I had a close personal encounter with a ship that was so real it was undeniable. I was beamed onto a ship to communicate with my galactic family. There were no words communicated to me but a tremendous feeling of love. Where I had initially felt fear, it melted and was replaced with love and gratitude.
Two days later my twin flame and I began seeing ships in the night sky. We could confirm that these were not stars or satellites because they pulsated light when we asked them questions and acknowledged them. They actually moved around in many directions, freezing when airplanes would come close to them. There have been many exciting encounters throughout the month of September and now October (time of video posting) which have been shared with Koreans and other foreigners. See my article on
Extremely painful and destructive, gout is the most common form of inflammatory arthritis with elevated serum uric acid (sUA) a root cause of the disease. Even with the growing incidence of gout, recent research from the Gout & Uric Acid Education Society (GUAES) found that just 16 percent of Americans overall know the target sUA number for gout (6 mg/dL or below) – and just 38 percent of people with gout had their sUA levels checked within the past six months, the timeframe recommended by the American College of Rheumatology. Additionally, the majority of gout sufferers don’t understand the importance of taking daily uric acid-lowering medications, with four in 10 incorrectly believing that they can stop taking medications when they aren’t experiencing flares.
Seeking to increase recognition of the severity of gout and need for routine sUA testing and management, GUAES hosted a professional roundtable discussion on October 3, 2015. The roundtable brought together several experts – rheumatologists, a family care physician, and representatives from the American Association of Diabetes Educators, the National Kidney Foundation and CreakyJoints – to explore how to more effectively educate about gout and improve access to public education and treatment.
To view the multimedia release go to:
http://www.multivu.com/players/English/7715851-guaes-gout-roundtable-discussion/
After analyzing millions of Internet visits and interviewing scores of consumers, Brookdale Senior Living has built a new website based on fresh insights into what’s most important to families searching for senior care. The first phase, which is a $4 million investment, went live on brookdale.com mid-August.
“With Brookdale’s website attracting more than 500,000 visits every month, it’s imperative to make it as useful to consumers as possible,” said David Cygan, Brookdale’s senior vice president of marketing. “As the nation’s largest senior living provider, we know our website is a primary source of information, with many people coming to us first as they embark on this journey,” Cygan said. “It’s important that we offer substantive resources that make it easier to find help in evaluating senior care options.” More than 80 percent of adult children turn to the Internet when they look for care for an aging parent, according to the company’s research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7722159-new-brookdale-senior-living-website/
Seeking to support men and their loved ones facing the challenges that come with a diagnosis of prostate cancer, USA Rugby, the Australian Rugby Union and Astellas Pharma have partnered to launch the #pass4prostate challenge, a social media campaign designed to generate awareness of prostate cancer and support a donation of up to $125,000 from Astellas to four research and advocacy organizations: Prostate Cancer Foundation, Australia Prostate Cancer Research, Prostate Cancer Foundation Australia and Prostate Cancer Canada.
From August 5 through the end of September – Prostate Cancer Awareness Month – social media users are encouraged to record a video of themselves catching an inanimate object, mentioning why prostate cancer awareness is important to them, and then passing that object, rugby-style, symbolically to a friend or family member. Astellas will donate $5 to prostate cancer advocacy organizations for every qualifying submission with the #pass4prostate hashtag posted to Facebook, Twitter or Instagram, up to a maximum contribution of $125,000.
To view the multimedia release visit:
http://www.multivu.com/players/English/7579051-pass4prostate-challenge-rugby-astellas/
SC Johnson, the world's leading manufacturer of pest control products, is using its 60 years of insect expertise to educate consumers as the Zika virus continues to spread. Immediately following the initial outbreak in Brazil, the company assembled its experts and began developing educational resources for consumers to understand how to best protect themselves against mosquitoes that may carry disease.
In addition to educating consumers, SC Johnson is actively working with organizations around the world to donate and distribute product to those in need. In coordination with the U.S. Centers for Disease Control and Prevention (CDC) Foundation, SC Johnson supported the Zika Action Plan Summit held by the White House and the CDC on April 1, and also donated to the CDC's Zika Prevention Kits. Additional donations have been made to AmeriCares, the Rio de Janeiro-based Children’s Health Association and the County of Hawaii Civil Defense Agency.
For nearly 60 years, SC Johnson entomologists have studied insects at the Entomology Research Center in Racine, Wis., the world's largest private, urban entomology research center. In their research, they help SC Johnson create products that consumers can trust and to provide them with the right product for their pest control needs. SC Johnson is the world's largest manufacturer of insect repellent and household insecticides, including OFF!®, Raid®, Autan® and Baygon®.
To view the multimedia release go to:
http://www.multivu.com/players/English/7787731-sc-johnson-zika-mosquito-protection/
